Shigeru Goto

Title: Shigeru Goto: Innovator in Immunology

Introduction

Shigeru Goto is a prominent inventor based in Oita-ken, Japan. He has made significant contributions to the field of immunology, particularly through his innovative patents. With a total of three patents to his name, Goto's work focuses on monoclonal antibodies and their applications in medical science.

Latest Patents

One of Goto's latest patents is a monoclonal antibody having immunosuppressive activity or an antigen binding fragment thereof. This invention relates to a monoclonal antibody that exhibits excellent immunosuppressive activity, specifically binding to a peptide with the amino acid sequence SSVLYGGPPSAA. The antibody demonstrates a higher binding affinity for core histone compared to histone H1. Another significant patent is for an anti-histone H1 monoclonal antibody and the hybridoma for its production. This invention is crucial for suppressing, predicting, or diagnosing transplant rejection in organ transplantation.

Career Highlights

Shigeru Goto has worked with notable organizations such as Amateraspharma Inc. and Josai University Corporation. His experience in these institutions has allowed him to advance his research and contribute to the development of innovative medical solutions.

Collaborations

Goto has collaborated with esteemed colleagues, including Takeshi Goto and Shuji Sato. Their combined expertise has further enhanced the impact of Goto's inventions in the field of immunology.

Conclusion

Shigeru Goto's contributions to immunology through his patents highlight his role as an influential inventor. His work on monoclonal antibodies has the potential to significantly impact medical practices, particularly in organ transplantation.